Issaquah, WA, United States of America

Yue Yao

This inventor holds 22 USPTO granted patents and 5 published patent applications and 2 EPO patents, primarily in Neuronal Inflammation. Top assignees: Zymogenetics, Inc., Octadem Technologies, Inc.. Active years: 2007-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yue Yao. Retrieved from https://idiyas.com/inventor/yue-yao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 

% Patents Active = 95.5

 

Average Co-Inventor Count = 2.2

ph-index = 12

Forward Citations = 426(Granted Patents)


Location History:

  • Kenmore, WA (US) (2007)
  • Issaquah, WA (US) (2008 - 2017)

Company Filing History:


Years Active: 2007-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
IL-31 Monoclonal Antibodies
Neuronal Inflammation
Signal Transduction
Pain Treatment
PDGFRbeta Inhibition
VEGF-A Inhibition
OSMR-b Antagonist
Dorsal Root Ganglion
Spinal Cord Cells
Neuronal Tissue
UMLR Polypeptides
Compact Spectral Readers
22 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Yue Yao in Neuroinflammation Research

Introduction

Yue Yao, located in Issaquah, WA, is a prominent inventor with a portfolio that boasts 22 patents. His groundbreaking work primarily focuses on the treatment of neuronal inflammation, which has significant implications for clinical practices in neurology.

Latest Patents

Yue Yao's recent patents highlight innovative approaches using monoclonal antibodies for managing neuronal inflammation. The first patent involves the "Use of IL-31 monoclonal antibodies for treating neuronal inflammation." This invention utilizes antagonists to IL-31, which are capable of treating inflammation and pain by inhibiting stimulation in neuronal tissues. These antagonists, including antibodies and their derivatives, effectively ameliorate symptoms associated with neuropathies, such as pain, tingling, and sensitization.

Another noteworthy patent is the "Use of IL-31RA monoclonal antibodies for treating neuronal inflammation." This invention employs antagonists to IL-31RA and OSMRb to address inflammation and pain. Similar to his previous work, these antagonists also consist of soluble receptors and antibodies that aim to minimize stimulation in neuronal tissues, providing relief from neuropathic symptoms.

Career Highlights

Yue Yao has made substantial contributions to the field of science throughout his career, particularly during his tenure at Zymogenetics, Inc. and Octadem Technologies, Inc. His work in these companies has greatly facilitated advancements in understanding and treating neurological conditions.

Collaborations

Yue Yao has collaborated with various professionals throughout his career, including notable coworkers such as Janine M. Bilsborough and Scott R. Presnell. These collaborations have enriched his research and patent development, fostering innovation within the field.

Conclusion

Yue Yao's innovative contributions to neuronal inflammation treatments through his patents reflect a dedication to advancing medical science. His work not only improves the understanding of neurological conditions but also provides promising avenues for therapeutic interventions, showcasing the importance of innovation in addressing complex health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…